The American Headache Society (AHS) has issued a position statement advocating for yearly diagnostic screening for migraine in girls and women, a move aimed at improving diagnosis rates and treatment access for a condition that often goes unrecognized. This recommendation extends from adolescence through menopause, a period when migraine incidence and prevalence are particularly high.
Migraine is a highly prevalent neurological disorder with significant impacts on quality of life, yet it remains widely underdiagnosed and undertreated. The AHS asserts that migraine fulfills the established criteria for conditions where routine screening is appropriate, citing its high prevalence, substantial morbidity, and considerable economic and social costs. The position statement emphasizes the availability of valid and reliable screening tools, such as the ID Migraine screener, and effective treatments to manage migraine symptoms.
The Need for Proactive Screening
The call for routine screening stems from a recognition that many individuals suffering from migraine do not receive a formal diagnosis. This lack of diagnosis can lead to delayed or inadequate treatment, resulting in prolonged suffering and diminished well-being. According to the AHS, screening enables more patients to receive timely, appropriate, and effective management. The position statement was developed following established guidelines from the AHS Guidelines Committee and was reviewed and approved by the AHS Board of Directors.
Migraine affects women at a disproportionately higher rate than men, and hormonal fluctuations throughout a woman’s life – from menstruation to pregnancy and menopause – can significantly influence migraine patterns. The AHS position statement specifically targets this demographic, recognizing the unique challenges women face in accessing appropriate migraine care. The recommendation for yearly screening is intended to integrate migraine assessment into standard women’s preventive healthcare services.
Screening Tools and Effective Treatments
The AHS highlights the importance of utilizing validated screening tools to efficiently identify individuals who may be experiencing migraine. Tools like ID Migraine are designed to quickly and accurately assess the likelihood of migraine, facilitating further diagnostic evaluation when necessary.
Beyond diagnosis, the AHS emphasizes the availability of effective treatments for migraine. These treatments range from acute medications to alleviate symptoms during an attack to preventative therapies aimed at reducing the frequency and severity of migraines. Access to these treatments is significantly improved when migraine is accurately diagnosed through routine screening. The American Headache Society’s clinical practice guidelines provide comprehensive guidance for healthcare professionals on the management of migraine and other headache disorders.
Future Directions in Migraine Care
The AHS is also focused on developing standardized processes for onboarding advanced practice providers into headache medicine practices in the United States, as outlined in a recently published consensus statement. This initiative, published in January 2026, aims to enhance the quality and accessibility of migraine care by ensuring that all healthcare professionals involved in migraine management are adequately trained and equipped.
The implementation of routine migraine screening represents a significant step towards improving the lives of millions of women affected by this debilitating condition. Continued research and advancements in treatment options will further enhance the ability to effectively manage migraine and minimize its impact on individuals and society. The AHS position statement underscores the importance of proactive healthcare and the need to prioritize the diagnosis and treatment of migraine as a standard of care for women’s health.
What impact do you think this new recommendation will have on migraine diagnosis rates? Share your thoughts in the comments below.
Disclaimer: This article provides informational content only and is not intended to be a substitute for professional medical advice. Always consult with a qualified healthcare provider for diagnosis and treatment of any medical condition.
